Loss of HIV Virologic Control Originating in the Cerebrospinal Fluid Due to Inadvertent Protease Inhibitor Monotherapy
Eavan G. Muldoon*, Michael R. Jordan, and Susan Hadley
Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA, USA
- *Corresponding Author:
- Eavan G. Muldoon
Division of Geographic Medicine and Infectious Diseases
Tufts Medical Center
800 Washington Street, Boston, USA
Tel: 617 636 7001
Fax: 617 636 1580
E-mail: [email protected]
Received Date: May 23, 2013; Accepted Date: July 13, 2013; Published Date: July 25, 2013
Citation: Muldoon EG, MPH, Jordan MR, Hadley S (2013) Loss of HIV Virologic Control Originating in the Cerebrospinal Fluid Due to Inadvertent Protease Inhibitor Monotherapy. J AIDS Clin Res 4:219. doi:10.4172/2155-6113.1000219
Copyright: © 2013 Muldoon EG, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
There is increasing recognition that the ongoing replication of Human Immunodeficiency Virus (HIV) within the central nervous system can have important prognostic implications, both in terms of HIV control and neurological symptoms. We present a case of loss of HIV virological control in a patient receiving unintended protease inhibitor monotherapy.